Urgent Need for Collaboration: Addressing Ukraine's Mental Health Crisis Through Psychedelic-Assisted Therapy

The scale of human suffering caused by the war in Ukraine and the degree of unmet mental health needs create a sense of urgency and call for increased collaboration.

PAREA’s Founded visited Kyiv in August and signed a Memorandum of Understanding with the  Ukrainian Psychedelic Research Association.

During this difficult time for the psychedelic medicines field, with the FDA's imminent approval of MDMA-assisted therapy seeming very unlikely, we must do all we can to open up safe and equitable access to psychedelics for people in Ukraine who have developed treatment-resistant PTSD and don't have the luxury of time or much of a treatment choice.

It is impressive and encouraging to see the incredible work that UPRA and many other groups and individuals are doing to make this a reality.

During his visit, PAREA’s Tadeusz Hawrot also visited the Forest Glade veterans mental health centre, where a pilot study on MDMA-assisted therapy is being prepared, and met with its Director, Kseniia Voznitsyna. The study has been approved by the Health Ministry and will likely start in about half a year.

Following the June workshop “Psychedelics for Healing War-Induced Trauma” with Ukrainian participants and international experts that PAREA organized in Warsaw, PAREA is now creating several expert groups to support the progress taking place in Ukraine.